Your session is about to expire
← Back to Search
Positive Psychiatry for PTSD (RFPP Trial)
N/A
Recruiting
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
RFPP Trial Summary
This trial is testing a new trauma focused intervention called reminder focused positive psychiatry (RFPP) to see if it is associated with improved core PTSD symptoms, decreased severity of reactivity to PTSD trauma reminders, and increased vascular function in adolescents with PTSD.
Who is the study for?
This trial is for boys and girls aged 11-15 with documented PTSD. They must be able to read and write in English. It's not for those with substance use disorders, other neurodevelopmental disorders, psychotic or self-injurious behavior, seizure or language disorders, intellectual disabilities, or eye disorders.Check my eligibility
What is being tested?
The study tests Reminder Focused Positive Psychiatry (RFPP) against an attention control group process in adolescents with PTSD. Participants will receive telehealth sessions twice a week for six weeks and undergo assessments at multiple points to measure the intervention's impact on PTSD symptoms and biomarkers.See study design
What are the potential side effects?
While specific side effects are not detailed here, RFPP is considered well tolerated based on previous observations. Potential side effects may relate to emotional discomfort due to discussing traumatic events during therapy.
RFPP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To examine the impact of RFPP intervention on core PTSD symptoms
Secondary outcome measures
To assess the impact of RFPP on well-being of adolescents with PTSD and their parents
To examine the impact of RFPP on biologic biomarkers, compared to control group
RFPP Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: RFPP group interventionActive Control1 Intervention
The focus of RFPP is on enhancing contextual discrimination and emotional regulation, and promoting the use of adaptive coping strategies in response to trauma reminders, including recognizing reminders, shifting attention from intrusive memories during exposure to reminders to a focus on positive feelings, thoughts, goals, and choices.
Group II: attentional control condition (group process)Placebo Group1 Intervention
Subjects will receive progressive muscle relaxation and other relaxation techniques as well as education about PTSD and supportive psychotherapy. Parents will receive 4 sessions of relaxation techniques.
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,533 Previous Clinical Trials
10,265,508 Total Patients Enrolled
UCLA Cousins Center for PsychoneuroimmunologyUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are a boy or girl who has been diagnosed with PTSD.You have been diagnosed with drug or alcohol addiction.You are between the ages of 11 and 15.You have other conditions that affect your brain development.You have shown behavior where you harm yourself or have experienced hallucinations or delusions.You have a medical condition that causes seizures.You have difficulty communicating due to a language disorder.You are between 11 and 15 years old.You have an intellectual disability.You have an eye condition.You have been diagnosed with PTSD (post-traumatic stress disorder).
Research Study Groups:
This trial has the following groups:- Group 1: RFPP group intervention
- Group 2: attentional control condition (group process)
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there currently any opportunities to join this research endeavor?
"Affirmative. According to clinicaltrials.gov, this medical trial is presently recruiting participants, with the first post dating back to May 1st 2022 and subsequent updates as recently as May 16th 2022. The study seeks 60 qualified individuals from a single location."
Answered by AI
Does this medical research include individuals who are octogenarians?
"This trial is specially designed for children between the age of 11 and 15. According to clinicaltrials.gov, there are 46 medical studies available for minors below 18 years old and 328 trials that cater to adults over 65."
Answered by AI
Am I eligible to participate in this experiment?
"This medical trial is recruiting 60 patients, aged 11 to 15 years old, who have been diagnosed with stress or trauma disorders."
Answered by AI
How many participants are receiving treatment as part of this clinical study?
"Indeed, clinicaltrials.gov is showing that this medicinal experiment has been actively recruiting since May 1st 2022 and its most recent update was on the 16th of the same month. The study needs to enrol 60 patients from a single medical facility."
Answered by AI
Who else is applying?
What state do they live in?
California
How old are they?
65+
What site did they apply to?
UCLA
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger